Fig. 2From: Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000–2013Tyrosine kinase inhibitor penetrance for treatment of CML in LithuaniaBack to article page